Cary, NC, United States of America

Dennis Michael Lambert

USPTO Granted Patents = 24 

 

Average Co-Inventor Count = 3.2

ph-index = 14

Forward Citations = 356(Granted Patents)


Location History:

  • Durham, NC (US) (2003)
  • Fair Oaks, CA (US) (2004)
  • Cary, NC (US) (2000 - 2010)

Company Filing History:

goldMedal21 out of 31 
 
Trimeris, Inc.
 patents
silverMedal2 out of 2,007 
 
Duke University
 patents
bronzeMedal2 out of 832,680 
Other
 patents
where one patent can have more than one assignee

Years Active: 2000-2010

Loading Chart...
Loading Chart...
24 patents (USPTO):

Title: Dennis Michael Lambert: Innovator in Viral Inhibition

Introduction

Dennis Michael Lambert, based in Cary, NC, is a distinguished inventor with a notable portfolio encompassing 22 patents. His work primarily focuses on the development of innovative peptides with significant antiviral properties, particularly against human immunodeficiency virus (HIV) and hepatitis B virus (HepB).

Latest Patents

Some of Lambert's latest patents include isolated peptides derived from HIV types 1 and 2, which contain fusion inhibitory domains exhibiting potent anti-retroviral activities. One of the key innovations, the DP178 peptide, targets amino acids 638 to 673 of the HIV-1 gp41 protein. This invention also describes various fragments, analogs, and homologs of DP178, emphasizing their use in preventing both human and non-human retroviral transmission to uninfected cells. Another significant patent outlines methods using peptides homologous to DP-178 and DP-107 for inhibiting Hepatitis B virus transmission to uninfected cells, demonstrating their dual utility in the realm of viral infections.

Career Highlights

Throughout his career, Dennis Lambert has worked with prominent organizations, including Trimeris, Inc. and Duke University. His contributions in these settings have significantly advanced the field of virology, particularly in the area of therapeutic developments aimed at viral infections.

Collaborations

Lambert's innovative journey has been enriched by collaborations with notable colleagues such as Shawn O'Lin Barney and Stephen Robert Petteway. These partnerships have fostered a dynamic exchange of ideas and facilitated groundbreaking research in peptide technology and antiviral therapies.

Conclusion

Dennis Michael Lambert's work exemplifies the crucial intersection of innovative science and practical application in the fight against viral diseases. His patents reflect a commitment to enhancing therapeutic options and advancing our understanding of viral inhibition mechanisms. As he continues to contribute to scientific advancements, Lambert's inventions pave the way for new treatments that could potentially transform the landscape of antiviral medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…